The correlation between SLC2A1 expression and eight immune checkpoints (CTLA4, PDCD1, TIGIT, LAG3, CD274, HAVCR2, PDCD1LG2, and SIGLEC15) was further investigated across multiple cancer types. Here, CD274 is linked to cancer.